You are advised, however, to consult any further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K, and 10-K filed with the Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties. SEC Filings

Third, whatever the setting, never discuss prices, terms of sale, output levels, or allocating customers or markets with any competitor. Record and document in your files the source of your information about competitors (if it is not already clear from the context). ✓ Document the source and date of receipt of all competitors’ price lists and other competitive data contained in your files

Reporting & SEC Filings

Reporting & SEC Filings

FILE

Registered Drug Master File (DMF) / Device Master File (MAF) NAME

PolyOne Completes Clariant Masterbatch Acquisition, Announces New Name: Avient Corporation... Reporting & SEC Filings

PolyOne Names Dr. Reporting & SEC Filings

PolyOne Completes Clariant Masterbatch Acquisition, Announces New Name: Avient Corporation SEC Filings

PolyOne Names Dr. SEC Filings